• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Rocket Lab Announces First Quarter 2024 Financial Results Reflecting Year-on-Year Revenue Growth of 69%, Sequential Quarterly Growth of 55%, and Continued Growth in Q2 2024

    5/6/24 4:35:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials
    Get the next $RKLB alert in real time by email

    Rocket Lab also provided a major update on the progress of its new rocket Neutron, including that it has completed its first Archimedes engine build and has begun its engine test campaign in Mississippi

    Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2024.

    Rocket Lab founder and CEO Peter Beck said: "Rocket Lab has had a strong start to the year, with our four Electron missions in Q1 marking an accelerated cadence of launches this year and maintaining our status as operators of the United States' second most frequently launched rocket. Most recently we were awarded close to $50 million across two mission contracts post quarter for the United States Space Force's Space Systems Command: the Victus Haze responsive space demonstration with Electron and a Rocket Lab Pioneer-class satellite that must launch within 24 hours' notice, and the next mission in the Space Systems Command's Space Test Program that will lift-off from our launch pad in Virginia. Both missions are a further demonstration of Rocket Lab as a trusted partner to the Department of Defense for assured access to space, coming off the back of our fifth overall national security launch for the National Reconnaissance Office which we flew before quarter-end in March.

    "In our Space Systems business, execution on our $515m constellation build program for the Space Development Agency has begun in earnest with a successful program kick-off, completed preliminary design studies for the constellation's 18 spacecraft, and the selection and onboarding of the program's subcontractors who will contribute across various mission requirements. Other major spacecraft programs, including our 17 spacecraft constellation build for MDA and Globalstar, our twin spacecraft to Mars for the NASA ESCAPADE mission, and our mission support and reentry spacecraft for Varda, also cleared significant delivery, build, and test milestones that advance the programs and maintain schedule for launches or deliveries this year.

    "For Neutron, we've also achieved major development milestones to date this year, including the first assembly of an Archimedes engine, now ready for a hot fire engine test campaign at our facilities at NASA Stennis in Mississippi. The Archimedes test site at Stennis is also now commissioned and ready to support the upcoming test campaign, the results of which will be the driver of Neutron's expected date for first launch. Now with a complete engine, we're through some of the unknowns in the development program and can update the schedule for first flight accordingly, which we have adjusted to no earlier than mid-2025.

    "Other developments across the program include major installations at the Neutron launch pad in Wallops, Virginia, such as completed concrete pours for the site's launch mount and finalization of the site's 278 ft water tower, forever changing the Wallops Island skyline and marking an exciting new era in Neutron's path to first launch."

    First Quarter 2024 Business Highlights:

    • Closed Q1 2024 with $1+ billion in backlog.
    • Successfully launched four Electron missions for commercial and national security customers across our launch sites in the United States and New Zealand.
    • Successful program kick-off as the prime contractor for a $515m Space Development Agency contract to design, build and operate 18 satellites for the Tranche 2 Transport Layer-Beta.
    • Meaningful progress made on the production and testing of two Rocket Lab spacecraft for NASA's ESCAPADE mission to Mars.
    • Successfully returned a spacecraft to Earth for Varda in a world-first in-space manufacturing mission, enabling Varda's payload of pharmaceutical crystals made in space to return to Earth.
    • Progressed major infrastructure milestones at Launch Complex 3 for Neutron, including foundations for the launch mount, water tower and liquid oxygen tanks.

    Business Highlights Since March 31, 2024:

    • First launch of the quarter successfully completed for KAIST and NASA.
    • Completed the assembly of an Archimedes engine for the first time ahead of upcoming engine test campaign at NASA Stennis in Mississippi.
    • Completed major infrastructure installations at Launch Complex 3 for Neutron in Virginia, including the final concrete pour for Neutron's launch mount and finalization of the site's 278 ft water tower.
    • Awarded a $32 million end-to-end launch-plus-spacecraft contract with the U.S. Space Force's Space Systems Command for a 24-hour notice responsive space demonstration.
    • Awarded a second U.S. Space Force launch contract valued at $14.49 million for the Space System Command's Space Test Program (STP).

    Second Quarter 2024 Guidance

    For the second quarter of 2024, Rocket Lab expects:

    • Revenue between $105 million and $110 million.
    • Space Systems revenue between $77 million and $81 million.
    • Launch Services revenue between $28 million and $29 million.
    • GAAP Gross Margins between 24% and 26%.
    • Non-GAAP Gross Margins between 30% and 32%.
    • GAAP Operating Expenses between $74 million and $76 million.
    • Non-GAAP Operating Expenses between $62 million and $64 million.
    • Expected Interest Expense (Income), net $1 million.
    • Adjusted EBITDA loss of $23 million to $25 million.
    • Basic Shares Outstanding of 494 million.

    See "Use of Non-GAAP Financial Measures" below for an explanation of our use of Non-GAAP financial measures, and the reconciliation of historical Non-GAAP measures to the comparable GAAP measures in the tables attached to this press release. We have not provided a reconciliation for the forward-looking Non-GAAP Gross Margin, Non-GAAP Operating Expenses or Adjusted EBITDA expectations for Q2 2024 described above because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. Stock-based compensation is currently expected to range from $14 million to $15 million in Q2 2024.

    Conference Call Information

    Rocket Lab will host a conference call for investors at 2 p.m. PT (5 p.m. ET) today to discuss these business highlights and financial results for our first quarter, to provide our outlook for the second quarter, and other updates.

    The live webcast and a replay of the webcast will be available on Rocket Lab's Investor Relations website: https://investors.rocketlabusa.com/events-and-presentations/events.

    About Rocket Lab

    Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufacture, spacecraft components, and on-orbit management solutions that make it faster, easier, and more affordable to access space. Headquartered in Long Beach, California, Rocket Lab designs and manufactures the Electron small orbital launch vehicle, our family of spacecraft platforms, and the Company is developing the large Neutron launch vehicle for constellation deployment. Since its first orbital launch in January 2018, Rocket Lab's Electron launch vehicle has become the second most frequently launched U.S. rocket annually and has delivered 180+ satellites to orbit for private and public sector organizations, enabling operations in national security, scientific research, space debris mitigation, Earth observation, climate monitoring, and communications. Rocket Lab spacecraft have been selected to support NASA missions to the Moon and Mars, as well as the first private commercial mission to Venus. Rocket Lab has three launch pads at two launch sites, including two launch pads at a private orbital launch site located in New Zealand and a third launch pad in Virginia. To learn more, visit www.rocketlabusa.com.

    + FORWARD-LOOKING STATEMENTS

    This press release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release, including statements regarding our expectations of financial results for the second quarter of 2024, strategy, future operations, future financial position, projected costs, prospects, plans and objectives of management, are forward-looking statements. Words such as, but not limited to, "anticipate," "aim," "believe," "contemplate," "continue," "could," "design," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "seek," "should," "suggest," "strategy," "target," "will," "would," and similar expressions or phrases, or the negative of those expressions or phrases, are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are based on Rocket Lab's current expectations and beliefs concerning future developments and their potential effects. These forward-looking statements involve a number of risks, uncertainties (many of which are beyond Rocket Lab's control), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including risks related to delays and disruptions in expansion efforts; delays in the development of our Neutron rocket; our dependence on a limited number of customers; the harsh and unpredictable environment of space in which our products operate which could adversely affect our launch vehicle and spacecraft; increased competition in our industry due in part to rapid technological development; technological change in our industry which we may not be able to keep up with or which may render our services uncompetitive; average selling price trends; general economic uncertainty and turbulence which could impact our customers' ability to pay what we are owed; failure of our launch vehicles, spacecraft and components to operate as intended either due to our error in design, in engineering, in production or through no fault of our own; launch schedule disruptions; supply chain disruptions, product delays or failures; launch failures; natural disasters and epidemics or pandemics; any inability to effectively integrate recently acquired assets; a US government shutdown or delays in government funding; changes in governmental regulations including with respect to trade and export restrictions, or in the status of our regulatory approvals or applications; or other events that force us to cancel or reschedule launches, including customer contractual rescheduling and termination rights; risks that acquisitions may not be completed on the anticipated time frame or at all or do not achieve the anticipated benefits and results; and the other risks detailed from time to time in Rocket Lab's filings with the Securities and Exchange Commission (the "SEC"), including under the heading "Risk Factors" in Rocket Lab's Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on February 28, 2024, and elsewhere. There can be no assurance that the future developments affecting Rocket Lab will be those that we have anticipated. Except as required by law, Rocket Lab is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

    Notes to Editor: All dollar amounts in this press release are expressed in U.S. dollars, unless otherwise stated.

    + USE OF NON-GAAP FINANCIAL MEASURES

    We supplement the reporting of our financial information determined under Generally Accepted Accounting Principles in the United States of America ("GAAP") with certain non-GAAP financial information. The non-GAAP financial information presented excludes certain significant items that may not be indicative of, or are unrelated to, results from our ongoing business operations. We believe that these non-GAAP measures provide investors with additional insight into the company's ongoing business performance. These non-GAAP measures should not be considered in isolation or as a substitute for the related GAAP measures, and other companies may define such measures differently. We encourage investors to review our financial statements and publicly filed reports in their entirety and not to rely on any single financial measure. Reconciliation of the non-GAAP financial information to the corresponding GAAP measures for the historical periods disclosed are included at the end of the tables in this press release. We have not provided a reconciliation for forward-looking non-GAAP financial measures because, without unreasonable efforts, we are unable to predict with reasonable certainty the amount and timing of adjustments that are used to calculate these non-GAAP financial measures, particularly related to stock-based compensation and its related tax effects. The following definitions are provided:

    + ADJUSTED EBITDA

    EBITDA is defined as earnings before interest, taxes, depreciation and amortization. Adjusted EBITDA further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from net income or loss to determine Adjusted EBITDA. Management believes this measure provides investors meaningful insight into results from ongoing operations.

    + OTHER NON-GAAP FINANCIAL MEASURES

    Non-GAAP gross profit, research and development, net, selling, general and administrative, operating expenses, operating loss and total other income (expense), net, further excludes items of income or loss that we characterize as unrepresentative of our ongoing operations. Such items are excluded from the applicable GAAP financial measure. Management believes these non-GAAP measures provide investors meaningful insight into results from ongoing operations.

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS

    FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

    (unaudited; in thousands, except share and per share data)

     

     

     

    Three Months Ended March 31,

     

     

    2024

     

    2023

    Revenues

     

    $

    92,767

     

     

    $

    54,895

     

    Cost of revenues

     

     

    68,593

     

     

     

    48,538

     

    Gross profit

     

     

    24,174

     

     

     

    6,357

     

    Operating expenses:

     

     

     

     

    Research and development, net

     

     

    38,504

     

     

     

    23,905

     

    Selling, general and administrative

     

     

    28,749

     

     

     

    28,469

     

    Total operating expenses

     

     

    67,253

     

     

     

    52,374

     

    Operating loss

     

     

    (43,079

    )

     

     

    (46,017

    )

    Other income (expense):

     

     

     

     

    Interest expense, net

     

     

    (898

    )

     

     

    (685

    )

    Gain on foreign exchange

     

     

    311

     

     

     

    134

     

    Other (expense) income, net

     

     

    (589

    )

     

     

    1,477

     

    Total other (expense) income, net

     

     

    (1,176

    )

     

     

    926

     

    Loss before income taxes

     

     

    (44,255

    )

     

     

    (45,091

    )

    Provision for income taxes

     

     

    (5

    )

     

     

    (526

    )

    Net loss

     

    $

    (44,260

    )

     

    $

    (45,617

    )

    Net loss per share attributable to Rocket Lab USA, Inc.:

     

     

     

     

    Basic and diluted

     

    $

    (0.09

    )

     

    $

    (0.10

    )

    Weighted-average common shares outstanding:

     

     

     

     

    Basic and diluted

     

     

    489,994,709

     

     

     

    476,199,710

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED BALANCE SHEETS

    AS OF MARCH 31, 2024 AND DECEMBER 31, 2023

    (unaudited; in thousands, except share and per share data)

     

     

     

     

     

     

     

    March 31, 2024

    (unaudited)

     

    December 31,

    2023

    Assets

     

     

     

     

    Current assets:

     

     

     

     

    Cash and cash equivalents

     

    $

    365,929

     

     

    $

    162,518

     

    Marketable securities, current

     

     

    126,593

     

     

     

    82,255

     

    Accounts receivable, net

     

     

    31,167

     

     

     

    35,176

     

    Contract assets

     

     

    14,895

     

     

     

    12,951

     

    Inventories

     

     

    99,901

     

     

     

    107,857

     

    Prepaids and other current assets

     

     

    78,606

     

     

     

    66,949

     

    Assets held for sale

     

     

    8,532

     

     

     

    9,016

     

    Total current assets

     

     

    725,623

     

     

     

    476,722

     

    Non-current assets:

     

     

     

     

    Property, plant and equipment, net

     

     

    148,087

     

     

     

    145,409

     

    Intangible assets, net

     

     

    66,845

     

     

     

    68,094

     

    Goodwill

     

     

    71,020

     

     

     

    71,020

     

    Right-of-use assets - operating leases

     

     

    56,870

     

     

     

    59,401

     

    Right-of-use assets - finance leases

     

     

    14,827

     

     

     

    14,987

     

    Marketable securities, non-current

     

     

    68,566

     

     

     

    79,247

     

    Restricted cash

     

     

    3,849

     

     

     

    3,916

     

    Deferred income tax assets, net

     

     

    3,353

     

     

     

    3,501

     

    Other non-current assets

     

     

    22,884

     

     

     

    18,914

     

    Total assets

     

    $

    1,181,924

     

     

    $

    941,211

     

    Liabilities and Stockholders' Equity

     

     

     

     

    Current liabilities:

     

     

     

     

    Trade payables

     

    $

    25,995

     

     

    $

    29,303

     

    Accrued expenses

     

     

    9,091

     

     

     

    5,590

     

    Employee benefits payable

     

     

    13,934

     

     

     

    16,342

     

    Contract liabilities

     

     

    150,535

     

     

     

    139,338

     

    Current installments of long-term borrowings

     

     

    10,996

     

     

     

    17,764

     

    Other current liabilities

     

     

    21,911

     

     

     

    15,036

     

    Total current liabilities

     

     

    232,462

     

     

     

    223,373

     

    Non-current liabilities:

     

     

     

     

    Convertible senior notes, net

     

     

    343,829

     

     

     

    —

     

    Long-term borrowings, net, excluding current installments

     

     

    52,717

     

     

     

    87,587

     

    Non-current operating lease liabilities

     

     

    54,101

     

     

     

    56,099

     

    Non-current finance lease liabilities

     

     

    15,177

     

     

     

    15,238

     

    Deferred tax liabilities

     

     

    530

     

     

     

    426

     

    Other non-current liabilities

     

     

    4,162

     

     

     

    3,944

     

    Total liabilities

     

     

    702,978

     

     

     

    386,667

     

    COMMITMENTS AND CONTINGENCIES

     

     

     

     

    Stockholders' equity:

     

     

     

     

    Common stock, $0.0001 par value; authorized shares: 2,500,000,000; issued and outstanding shares: 492,670,716 and 488,923,055 at March 31, 2024 and December 31, 2023, respectively

     

     

    49

     

     

     

    49

     

    Additional paid-in capital

     

     

    1,148,484

     

     

     

    1,176,484

     

    Accumulated deficit

     

     

    (667,786

    )

     

     

    (623,526

    )

    Accumulated other comprehensive income (loss)

     

     

    (1,801

    )

     

     

    1,537

     

    Total stockholders' equity

     

     

    478,946

     

     

     

    554,544

     

    Total liabilities and stockholders' equity

     

    $

    1,181,924

     

     

    $

    941,211

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

    (unaudited; in thousands)

     

     

     

    For the Three Months Ended

    March 31,

     

     

    2024

     

    2023

    CASH FLOWS FROM OPERATING ACTIVITIES:

     

     

     

     

    Net loss

     

    $

    (44,260

    )

     

    $

    (45,617

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

     

    Depreciation and amortization

     

     

    8,313

     

     

     

    7,033

     

    Stock-based compensation expense

     

     

    13,093

     

     

     

    14,036

     

    Loss on disposal of assets

     

     

    3

     

     

     

    5

     

    Loss on extinguishment of long-term debt

     

     

    1,330

     

     

     

    —

     

    Amortization of debt issuance costs and discount

     

     

    639

     

     

     

    709

     

    Noncash lease expense

     

     

    1,491

     

     

     

    988

     

    Change in the fair value of contingent consideration

     

     

    (271

    )

     

     

    300

     

    Accretion of marketable securities purchased at a discount

     

     

    (842

    )

     

     

    (1,147

    )

    Deferred income taxes

     

     

    78

     

     

     

    420

     

    Changes in operating assets and liabilities:

     

     

     

     

    Accounts receivable, net

     

     

    3,939

     

     

     

    (14,116

    )

    Contract assets

     

     

    (1,944

    )

     

     

    (3,109

    )

    Inventories

     

     

    7,509

     

     

     

    (6,712

    )

    Prepaids and other current assets

     

     

    (5,303

    )

     

     

    (10,035

    )

    Other non-current assets

     

     

    (4,266

    )

     

     

    103

     

    Trade payables

     

     

    (1,673

    )

     

     

    11,305

     

    Accrued expenses

     

     

    3,200

     

     

     

    403

     

    Employee benefits payables

     

     

    (622

    )

     

     

    1,294

     

    Contract liabilities

     

     

    11,205

     

     

     

    17,292

     

    Other current liabilities

     

     

    6,729

     

     

     

    2,305

     

    Non-current lease liabilities

     

     

    (1,425

    )

     

     

    (891

    )

    Other non-current liabilities

     

     

    489

     

     

     

    49

     

    Net cash used in operating activities

     

     

    (2,588

    )

     

     

    (25,385

    )

    CASH FLOWS FROM INVESTING ACTIVITIES:

     

     

     

     

    Purchases of property, equipment and software

     

     

    (19,177

    )

     

     

    (12,674

    )

    Purchases of marketable securities

     

     

    (79,359

    )

     

     

    (76,394

    )

    Maturities of marketable securities

     

     

    46,280

     

     

     

    78,099

     

    Net cash used in investing activities

     

     

    (52,256

    )

     

     

    (10,969

    )

    CASH FLOWS FROM FINANCING ACTIVITIES:

     

     

     

     

    Proceeds from the exercise of stock options and public warrants

     

     

    943

     

     

     

    771

     

    Proceeds from Employee Stock Purchase Plan

     

     

    507

     

     

     

    1,202

     

    Proceeds from sale of employees restricted stock units to cover taxes

     

     

    5,119

     

     

     

    3,078

     

    Minimum tax withholding paid on behalf of employees for restricted stock units

     

     

    (5,163

    )

     

     

    (1,915

    )

    Payment of contingent consideration

     

     

    —

     

     

     

    (1,000

    )

    Purchase of capped calls related to issuance of convertible senior notes

     

     

    (43,168

    )

     

     

    —

     

    Proceeds from issuance of convertible senior notes

     

     

    355,000

     

     

     

    —

     

    Repayments on Trinity Loan Agreement

     

     

    (43,215

    )

     

     

    —

     

    Payment of debt issuance costs

     

     

    (11,226

    )

     

     

    —

     

    Finance lease principal payments

     

     

    (90

    )

     

     

    (78

    )

    Net cash provided by financing activities

     

     

    258,707

     

     

     

    2,058

     

    Effect of exchange rate changes on cash and cash equivalents

     

     

    (519

    )

     

     

    127

     

    Net increase (decrease) in cash and cash equivalents and restricted cash

     

     

    203,344

     

     

     

    (34,169

    )

    Cash and cash equivalents, and restricted cash, beginning of period

     

     

    166,434

     

     

     

    245,871

     

    Cash and cash equivalents, and restricted cash, end of period

     

    $

    369,778

     

     

    $

    211,702

     

    ROCKET LAB U.S.A., INC. AND SUBSIDIARIES

    RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

    FOR THE THREE MONTHS ENDED MARCH 31, 2024 AND 2023

    (unaudited; in thousands)

     

    The tables provided below reconcile the non-GAAP financial measures Adjusted EBITDA, Non-GAAP gross profit, Non-GAAP research and development, net, Non-GAAP selling, general and administrative, Non-GAAP operating expenses, Non-GAAP operating loss and Non-GAAP total other income (expense), net with the most directly comparable GAAP financial measures. See above for additional information on the use of these non-GAAP financial measures.

     

     

     

    Three Months Ended March 31,

     

     

    2024

     

    2023

    NET LOSS

     

    $

    (44,260

    )

     

    $

    (45,617

    )

    Depreciation

     

     

    4,924

     

     

     

    3,713

     

    Amortization

     

     

    3,389

     

     

     

    3,320

     

    Stock-based compensation expense

     

     

    13,093

     

     

     

    14,036

     

    Transaction costs

     

     

    372

     

     

     

    165

     

    Interest expense, net

     

     

    898

     

     

     

    685

     

    Change in fair value of contingent consideration

     

     

    (271

    )

     

     

    300

     

    Performance reserve escrow

     

     

    —

     

     

     

    1,838

     

    Provision for income taxes

     

     

    5

     

     

     

    526

     

    Gain on foreign exchange

     

     

    (311

    )

     

     

    (134

    )

    Accretion of marketable securities purchased at a discount

     

     

    (842

    )

     

     

    (1,165

    )

    Loss on disposal of assets

     

     

    3

     

     

     

    5

     

    Employee retention credit

     

     

    —

     

     

     

    (3,841

    )

    Loss on extinguishment of debt

     

     

    1,330

     

     

     

    —

     

    ADJUSTED EBITDA

     

    $

    (21,670

    )

     

    $

    (26,169

    )

     

     

    Three Months Ended March 31,

     

     

    2024

     

    2023

    GAAP Gross profit

     

    $

    24,174

     

     

    $

    6,357

     

    Stock-based compensation

     

     

    3,503

     

     

     

    3,813

     

    Amortization of purchased intangibles and favorable lease

     

     

    1,743

     

     

     

    1,710

     

    Performance reserve escrow

     

     

    —

     

     

     

    57

     

    Employee retention credit

     

     

    —

     

     

     

    (2,130

    )

    Non-GAAP Gross profit

     

    $

    29,420

     

     

    $

    9,807

     

    Non-GAAP Gross margin

     

     

    31.7

    %

     

     

    17.9

    %

     

     

     

     

     

    GAAP Research and development, net

     

    $

    38,504

     

     

    $

    23,905

     

    Stock-based compensation

     

     

    (3,985

    )

     

     

    (5,022

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (229

    )

     

     

    (9

    )

    Employee retention credit

     

     

    —

     

     

     

    631

     

    Non-GAAP Research and development, net

     

    $

    34,290

     

     

    $

    19,505

     

     

     

     

     

     

    GAAP Selling, general and administrative

     

    $

    28,749

     

     

    $

    28,469

     

    Stock-based compensation

     

     

    (5,605

    )

     

     

    (5,201

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (932

    )

     

     

    (1,434

    )

    Transaction costs

     

     

    (372

    )

     

     

    (165

    )

    Performance reserve escrow

     

     

    —

     

     

     

    (1,781

    )

    Change in fair value of contingent consideration

     

     

    271

     

     

     

    (300

    )

    Employee retention credit

     

     

    —

     

     

     

    1,080

     

    Non-GAAP Selling, general and administrative

     

    $

    22,111

     

     

    $

    20,668

     

     

     

     

     

     

    GAAP Operating expenses

     

    $

    67,253

     

     

    $

    52,374

     

    Stock-based compensation

     

     

    (9,590

    )

     

     

    (10,223

    )

    Amortization of purchased intangibles and favorable lease

     

     

    (1,161

    )

     

     

    (1,443

    )

    Transaction costs

     

     

    (372

    )

     

     

    (165

    )

    Performance reserve escrow

     

     

    —

     

     

     

    (1,781

    )

    Change in fair value of contingent consideration

     

     

    271

     

     

     

    (300

    )

    Employee retention credit

     

     

    —

     

     

     

    1,711

     

    Non-GAAP Operating expenses

     

    $

    56,401

     

     

    $

    40,173

     

     

     

     

     

     

    GAAP Operating loss

     

    $

    (43,079

    )

     

    $

    (46,017

    )

    Total non-GAAP adjustments

     

     

    16,098

     

     

     

    15,651

     

    Non-GAAP Operating loss

     

    $

    (26,981

    )

     

    $

    (30,366

    )

     

     

     

     

     

    GAAP Total other income (expense), net

     

    $

    (1,176

    )

     

    $

    926

     

    Gain on foreign exchange

     

     

    (311

    )

     

     

    (134

    )

    Loss on disposal of assets

     

     

    3

     

     

     

    5

     

    Loss on extinguishment of debt

     

     

    1,330

     

     

     

    —

     

    Non-GAAP Total other income (expense), net

     

    $

    (154

    )

     

    $

    797

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240506663287/en/

    Get the next $RKLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RKLB

    DatePrice TargetRatingAnalyst
    4/25/2025$28.00Buy
    Needham
    9/12/2024Mkt Perform
    JMP Securities
    7/15/2024$8.00 → $6.00Overweight → Equal-Weight
    Morgan Stanley
    6/26/2024Neutral
    BTIG Research
    6/11/2024$4.50Neutral
    Goldman
    2/12/2024$6.00Buy
    Citigroup
    1/17/2024$8.00Overweight
    KeyBanc Capital Markets
    10/26/2023$6.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $RKLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operations Officer Klein Frank sold $846,607 worth of shares (46,388 units at $18.25), decreasing direct ownership by 3% to 1,417,644 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:41:08 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Chief Financial Officer Spice Adam C. sold $1,142,574 worth of shares (62,843 units at $18.18), decreasing direct ownership by 5% to 1,196,679 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:35:37 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Officer Kampani Arjun sold $626,403 worth of shares (34,113 units at $18.36), decreasing direct ownership by 6% to 574,883 units (SEC Form 4)

      4 - Rocket Lab USA, Inc. (0001819994) (Issuer)

      3/18/25 8:35:28 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rocket Lab Partners With U.S. Air Force for Neutron Launch for Re-Entry Mission

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it will launch its new medium-lift reusable rocket Neutron for the U.S. Air Force Research Laboratory (AFRL) for a Rocket Cargo mission that supports point-to-point cargo transportation, establishing a new era of commercial launch capability to advance global defense logistics for the nation. The mission is scheduled for a return-to-Earth Neutron launch no earlier than 2026. The launch contract will see Neutron execute a Rocket Cargo survivability experiment under the AFRL Rocket Experimentation for Global Agile Logistics (REGAL) solicitation, an effort

      5/8/25 4:17:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces First Quarter 2025 Financial Results, Posting Quarterly Revenue of $123m Representing 32% Year-on-Year Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab," "the Company," "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2025. Rocket Lab founder and CEO Sir Peter Beck said: "Rocket Lab has delivered a strong first quarter performance, with wins across our launch and space systems divisions reflected in our near-record $123 million revenue – at the top end of our guidance and a 32% increase year-on-year compared to Q1 2024. We also remain confident in our ability to execute and deliver on what's set to be another strong quarter, with our Q2 2025 revenue guidance in the $130m-$140 million range

      5/8/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Schedules Next Mission for Multi-Launch Customer iQPS

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the launch window for its next mission for multi-launch customer, Institute for Q-shu Pioneers of Space, Inc. (iQPS). The mission, named ‘The Sea God Sees', will launch from Rocket Lab Launch Complex 1 in New Zealand during a launch window that opens on May 17, 2025. The mission will launch a single synthetic aperture radar (SAR) imaging satellite called QPS-SAR-10 (nicknamed "WADATSUMI-I" for the Japanese god of the sea) to a 575km circular Earth orbit, from where the satellite will join the rest of the iQPS constellation in providing high resolution im

      5/5/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    SEC Filings

    See more
    • SEC Form 10-Q filed by Rocket Lab USA Inc.

      10-Q - Rocket Lab USA, Inc. (0001819994) (Filer)

      5/8/25 4:30:52 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - Rocket Lab USA, Inc. (0001819994) (Filer)

      5/8/25 4:17:18 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form 10-K/A filed by Rocket Lab USA Inc.

      10-K/A - Rocket Lab USA, Inc. (0001819994) (Filer)

      4/30/25 4:05:56 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/5/24 9:49:25 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

      SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      12/3/24 9:39:57 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

      SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

      11/12/24 4:45:55 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Financials

    Live finance-specific insights

    See more
    • Rocket Lab Announces First Quarter 2025 Financial Results, Posting Quarterly Revenue of $123m Representing 32% Year-on-Year Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab," "the Company," "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal first quarter ended March 31, 2025. Rocket Lab founder and CEO Sir Peter Beck said: "Rocket Lab has delivered a strong first quarter performance, with wins across our launch and space systems divisions reflected in our near-record $123 million revenue – at the top end of our guidance and a 32% increase year-on-year compared to Q1 2024. We also remain confident in our ability to execute and deliver on what's set to be another strong quarter, with our Q2 2025 revenue guidance in the $130m-$140 million range

      5/8/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces Date of First Quarter 2025 Financial Results

      Rocket Lab USA, Inc. ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that it will release its financial results for the first quarter 2025 following the close of the U.S. markets on Thursday, May 8, 2025. Rocket Lab will host a corresponding conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). A live webcast and replay of the conference call will be available on the Company's Investor Relations website at www.rocketlabusa.com/investors. About Rocket Lab Founded in 2006, Rocket Lab is an end-to-end space company with an established track record of mission success. We deliver reliable launch services, satellite manufactu

      4/3/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Announces Full Year & Fourth Quarter 2024 Financial Results, Posts Record Revenue Representing 26% Sequential Growth, 78% Annual Growth and 121% Year-on-Year Quarterly Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab", "the Company", "we," "us," or "our"), a global leader in launch services and space systems, today shared the financial results for fiscal fourth quarter, ended December 31, 2024. Rocket Lab founder and CEO, Sir Peter Beck, said: "2024 was a record-setting year for Rocket Lab, with our highest annual revenue ever posted of $436.2 million and a record Q4 2024 revenue of $132.4 million – a 382% increase compared to Q4 2021, our first full quarter following our debut on the Nasdaq as a publicly-traded company. Top achievements across launch and space systems include a record number of 16 launches for Electron in 2024 (a 60% increase in launch

      2/27/25 4:15:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Leadership Updates

    Live Leadership Updates

    See more
    • Rocket Lab Awarded New HASTE Launch Contract for the DOD by Kratos

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced it has been selected by Kratos to launch a full-scale hypersonic test flight for the Department of Defense (DOD) under the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB) 2.0 program. The mission will launch on Rocket Lab's HASTE rocket from Rocket Lab Launch Complex 2 on Wallops Island, Virginia no earlier than Q1, 2026. The launch agreement is the first full-scale flight test to be awarded by Kratos under the MACH-TB 2.0 contract, a $1.45 billion program designed to rapidly expand the number and frequency of opportunities to test hypers

      4/23/25 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab Appoints Chief Operations Officer to Support Company Growth

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced the appointment of Frank Klein as its new Chief Operations Officer (COO), effective September 16th, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240910807125/en/Rocket Lab's new Chief Operations Officer, Frank Klein. (Photo: Business Wire) Frank Klein joins Rocket Lab with more than 30 years of international manufacturing experience and leadership in the automotive industry. At Rocket Lab, Mr. Klein will lead the Company's efforts to scale manufacturing of spacecraft, launch vehicles, a

      9/10/24 7:00:00 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Former Lockheed Martin Chief Financial Officer Joins Rocket Lab Board of Directors

      Rocket Lab USA, Inc. (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced that Kenneth (Ken) Possenriede has been appointed to the Company's Board of Directors. A seasoned executive with strong business and financial acumen, Mr. Possenriede joins Rocket Lab after a 35-year career at Lockheed Martin Corporation in financial leadership positions, including serving as Chief Financial Officer (CFO). "Ken's deep aerospace and defense industry experience, combined with accomplished financial leadership, adds even more horsepower to Rocket Lab's already impressive board line-up," said Rocket Lab's founder and Chief Executive Offic

      8/22/24 4:30:00 PM ET
      $RKLB
      Military/Government/Technical
      Industrials

    $RKLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham initiated coverage on Rocket Lab USA with a new price target

      Needham initiated coverage of Rocket Lab USA with a rating of Buy and set a new price target of $28.00

      4/25/25 8:32:44 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • JMP Securities initiated coverage on Rocket Lab USA

      JMP Securities initiated coverage of Rocket Lab USA with a rating of Mkt Perform

      9/12/24 9:09:33 AM ET
      $RKLB
      Military/Government/Technical
      Industrials
    • Rocket Lab USA downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Rocket Lab USA from Overweight to Equal-Weight and set a new price target of $6.00 from $8.00 previously

      7/15/24 7:47:38 AM ET
      $RKLB
      Military/Government/Technical
      Industrials